CVE:EMH Emerald Health Therapeutics (EMH) Stock Price, News & Analysis C$0.26 -0.01 (-3.77%) (As of 04/26/2021) Add Compare Share Share Stock Analysis Stock Analysis About Emerald Health Therapeutics Stock (CVE:EMH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get EMH alerts:Sign Up Key Stats Today's RangeC$0.25▼C$0.2750-Day RangeC$0.26▼C$0.2652-Week RangeC$0.15▼C$0.53Volume384,329 shsAverage Volume644,760 shsMarket CapitalizationC$52.28 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewEmerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.Read More… Ex WH Advisor Who Predicted Biden Leaving Race Makes Startling New Prediction (Ad)Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… Receive EMH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Emerald Health Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address EMH Stock News HeadlinesWomen’s Health Therapeutics Market Size to Reach USD 61.6 Billion by 2032, Driven by Rising Awareness & Technological Advancements - SNS InsiderOctober 17, 2024 | finance.yahoo.comEmerald PrincessMay 24, 2024 | travel.usnews.comUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?November 5, 2024 | Behind the Markets (Ad)University Hospitals Elyria Medical CenterSeptember 23, 2023 | health.usnews.comDigital Therapeutics (DTx) For Mental Health Market is Booming and Expected to Grow at a CAGR of 27.42% to 2031 | InsightAce StudyJuly 31, 2023 | finance.yahoo.comEfficient Market Hypothesis (EMH): Definition and CritiqueJuly 12, 2023 | investopedia.comRevolutionizing mental health treatment: Vistagen Therapeutics' nasal spray solutionJune 20, 2023 | finance.yahoo.comEmerald Care Center TulsaMay 4, 2023 | health.usnews.comSee More Headlines EMH Stock Analysis - Frequently Asked Questions How have EMH shares performed this year? Emerald Health Therapeutics' stock was trading at C$0.26 at the start of the year. Since then, EMH stock has increased by 0.0% and is now trading at C$0.26. View the best growth stocks for 2024 here. How do I buy shares of Emerald Health Therapeutics? Shares of EMH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What other stocks do shareholders of Emerald Health Therapeutics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Emerald Health Therapeutics investors own include Aurora Cannabis (ACB), Alibaba Group (BABA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Trulieve Cannabis (TCNNF) and Canopy Growth (WEED). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:EMH CUSIPN/A CIKN/A Webwww.emerald.care Phone+1-250-8189838FaxN/AEmployees161Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio35.45 Current Ratio2.97 Quick Ratio2.61 Sales & Book Value Annual SalesC$13.02 million Price / Sales4.02 Cash FlowC$0.33 per share Price / Cash Flow0.78 Book ValueC$0.40 per share Price / Book0.64Miscellaneous Outstanding Shares205,028,000Free FloatN/AMarket CapC$52.28 million OptionableNot Optionable BetaN/A 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report This page (CVE:EMH) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Emerald Health Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Emerald Health Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.